Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
23.18
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Amphastar Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Amphastar Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $22.5. The average 1-year stock price forecast is 2.93% lower than the current stock price, while the lowest is $20 (-13.72%) and the highest is $30 (+29.42%).

Price Target: $22.5 (-2.93%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$20$22.5$21$30
Change-13.72%-2.93%-9.40%+29.42%

Analyst Ratings

The average analyst rating for Amphastar Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy100000
Buy100000
Hold576666
Sell001111
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Hold
Maintains
$20
HoldMaintains$20-13.72%Sep 2, 2026
Barclays
Barclays
Hold
Maintains
$20$23
HoldMaintains$20$23-0.78%Aug 18, 2026
Needham
Needham
Hold
Maintains
$20
HoldMaintains$20-13.72%Aug 7, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
$21$20
HoldReiterates$21$20-13.72%Aug 7, 2026
Bank of America Securities
Bank of America Securities
Sell
Reiterates
$20
SellReiterates$20-13.72%Aug 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
747.75M
from 719.89M
Increased by 3.87%
Revenue Next Year
784.41M
from 747.75M
Increased by 4.90%
EPS This Year
2.97
from 3.25
Decreased by -8.57%
EPS Next Year
3.18
from 2.97
Increased by 7.07%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
437.77M498.99M644.40M731.97M719.89M747.75M
Revenue Growth
25.13%13.98%29.14%13.59%-1.65%3.87%
Gross Profit
199.74M248.86M351.12M373.86M356.06M375.62M
Gross Margin
45.63%49.87%54.49%51.08%49.46%50.23%
Operating Income
71.69M107.50M196.99M205.42M163.50M180.91M
Net Income
62.12M91.39M137.55M159.52M98.09M99.32M
EPS
----3.252.97
EPS Growth
-----15.80%-8.57%
Forward PE
16.9616.2920.779.427.787.80
Free Cash Flow
56.90M57.67M239.72M18.89M81.37M136.00M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High765.7M
Avg747.7M
Low710.9M

Revenue Growth

Revenue Growth202620272028
High
6.4%
Avg
3.9%
Low
-1.2%

EPS Forecast

EPS202620272028
High3.24
Avg2.97
Low2.59

EPS Growth

EPS Growth202620272028
High
-0.3%
Avg
-8.6%
Low
-20.3%